Clinical Research

Medidata NEXT NYC 2019 Delivers Roadmap for Future Innovation in Clinical Research | 11/14/2019

… and part of Dassault Systèmes, concluded its most successful NEXT NYC event to date. The two-day conference in New York City featured sessions essential to accelerating value, minimizing risk, and optimizing outcomes in clinical research and development: Best Practices for the Clinical Trial of Today - modernize and optimize trials to make them faster, cheaper and safer New Models for Clinical Development and Drug Approval - explore next-generation research design …

ATHENA: A Phase 3, Open-Label Study Of The Safety And Effectiveness Of Oliceridine (TRV130), A G-Protein Selective Agonist At The μ-Opioid Receptor, In Patients With Moderate To Severe Acute Pain Requiring Parenteral Opioid Therapy | 11/14/2019

Dr Nicola Ludin 3 Dr Katherine Hanlon Sergio D Bergese, 1 Marek Brzezinski, 2 Gregory B Hammer, 3 Timothy L Beard, 4 Peter H Pan, 5 Sharon E Mace, 6 Richard D Berkowitz, 7 Kristina Cochrane, 8 Linda Wase, 8 Harold S Minkowitz, 9 Ashraf S Habib 10 1 School of Medicine, Stony Brook University, Stony Brook, NY, USA; 2 School of Medicine, University of California San Francisco, VA Medical …

Follow Clinical Research:    

Polymer particles protect micronutrients to fortify food | 11/14/2019

A pH-sensitive polymer that keeps iron and vitamins from degrading during storage or cooking may help fight malnutrition Nestlé under fire in India for clinical research on preterm babies Credit: Science Translational Medicine Particles about 200 micrometers in diameter made from a polymer called BMC encapsulate micronutrients (dark spots) and protect them from degradation caused by heat, moisture and chemical exposure until they reach the stomach. A pH-sensitive …

Assistant/Associate Member Faculty Position in Prostate Cancer Research – Fred Hutchinson Cancer Research Center | Nature | 11/13/2019

Assistant/Associate Member Faculty Position in Prostate Cancer Research – Fred Hutchinson Cancer Research Center Fred Hutchinson Cancer Research Center Seattle, WA, United States Posted about 12 hours ago Expires on January 11, 2020 Description The Fred Hutchinson Cancer Research Center invites applications from scientists working in the area of prostate cancer research. Applicants will be considered at the rank of Assistant or Associate Faculty member, and we are seeking individuals …

Inequities in the global representation of sites participating in large, multicentre dialysis trials: a systematic review | BMJ | 11/13/2019

… complex, but include a commitment by a number of state governments to providing dialysis care within government-funded healthcare programmes. In resource-poor countries, it is particularly important that healthcare spending is effective and clinical research is conducted to inform clinicians and policymakers of the best use of their scarce resources. Much of the research conducted in high-income countries is restricted in its generalisability to countries with distinct populations …

Best Practices for Designing Decentralized Clinical Trials Through Robust Quality Management, Upcoming Webinar Hosted by Xtalks | PRWeb | 11/13/2019

On Thursday, December 5, 2019 at 10am EST (3pm GMT/UK), join Medical Research Network’s (MRN) Paul Bodfish, Vice President of Corporate Services and Andy Brown, Vice President of Business Quality Development in a live webinar where they will discuss: An overview of decentralized clinical trials Mitigating risk of decentralized solutions Shared benefits of continuous improvement What’s next Pharmaceutical companies are onboarding innovative solutions to decentralize clinical trials in an …

AMRA Medical Abstract Selected for AASLD’s “Best of The Liver Meeting” Showcase | PR Newswire | 11/13/2019

… Best of The Liver Meeting” slide-deck to be highlighted and for public distribution following The Liver Meeting 2019 in Boston . AMRA Medical is dedicated to supporting transformative care and vital decision-making from clinical research to health and wellness; AASLD highlighting this research is an honor that will expand AMRA’s reach to healthcare professionals. (PRNewsfoto/AMRA Medical) Sarcopenia – the gradual loss of muscle mass and function – is one of …

Javara And Privia Health Align To Integrate Clinical Trials Into The Patient Care Continuum | PR Newswire | 11/13/2019

… to match the right care to the right patient including the high touch options provided by clinical research,” said Keith Fernandez , MD, Privia Health’s Chief Clinical Officer. Javara provides resources and infrastructure to conduct clinical research and advance participation by initiating clinical trials to serve the interests of patients, while changing the landscape of medicine and health care. In addition to providing new treatment options for patients, incorporating clinical research

What will Clinical Research Look Like in 5, 10, 20 Years? Are We Heading to Heaven, Hell or Purgatory? Part 2 of 4 - Saama Technologies | 11/13/2019

… a broad range of therapeutic areas. He is an accomplished biopharmaceutical executive who is equally adept at shaping strategy and driving execution as well as nurturing culture. Jay held the position of SVP, Global Clinical Research & Development Operations at Celgene Corporation and was responsible for leading all Global Clinical R&D Operations functions in support of Celgene sponsored trials (200) phase I through IV across all therapeutic areas with combined …

Global Regenerative Medicine Market to Grow Over $81 Billion by 2023 and Market Driven by Stem Cells, Tissue Engineering, BioBanking & CAR-T Industries - ReportsnReports | PR Newswire | 11/13/2019

PUNE, India This report provides a comprehensive overview of the size of the regenerative medicine market, segmentation of the market (stem cells, tissue engineering and CAR-T therapy), key players and the vast potential of therapies that are in clinical trials. The analysis indicates that the global Regenerative Medicine Market was worth $28 billion in 2018 and will grow to over $81 billion by 2023, with a CAGR of 23.3 …

Oncolytics Biotech Inc. (ONCY) CEO Dr. Matt Coffey on Q3 2019 Results - Earnings Call Transcript | Seeking Alpha | 11/13/2019

… network and perhaps the preeminent breast cancer group in North America. The principal investigator will be PrECOG member Dr. Kathy Miller, Professor of Oncology at Indiana University School of Medicine and Associate Director of Clinical Research at Indiana University Melvin and Bren Simon in Cancer Center. I cannot overstate how happy we are to be working with this group on this critically important study on target patient population of hormone …

Syneos Health Collaborates with AiCure for Patient Engagement | Zacks | 11/13/2019

Syneos Health Collaborates with AiCure for Patient Engagement Zacks Equity Research You follow Analyst Blog - edit You follow Zacks Equity Research - edit What would you like to follow? Zacks Equity Research Cancel Read More Hide Full Article Syneos Health ( SYNH - Free Report ) recently collaborated with AI and advanced data analytics company AiCure to drive faster and smarter trials to optimize patient engagement. The partnership augments a pre-existing relationship, thus …

Worldwide Clinical Trials Taps Gerardo Pascuali as Clinical Operations Executive Director in Latin America | Business Wire | 11/13/2019

… organization (CRO), announced today the addition of Gerardo Pascuali as executive director for Latin America Clinical Operations. Based in Buenos Aires, Argentina, Pascuali will lead all operations in Latin America to support Worldwide’s growing clinical research team in the region. This new hire aids Worldwide’s continued efforts to expand its global footprint as sponsors’ clinical trial demands expand into new markets around the world. Small to midsize pharmaceutical and biotech …

Children’s Hospital Los Angeles Uncovers a New Frontier in Heart Tissue Regeneration Research | Business Wire | 11/13/2019

… also leads the largest pediatric residency training program at a freestanding children’s hospital of its kind in the western United States. The Saban Research Institute of Children’s Hospital Los Angeles encompasses basic, translational and clinical research conducted at CHLA. To learn more, follow us on Facebook , Instagram , LinkedIn and Twitter , and visit our blog for families ( CHLA.org/blog ) and our research blog ( ResearCHLABlog.org ). Contacts Media contact: Melinda Smith, [email protected]

The winners of the 2019 Nobel Prize in Economics are taking on the world’s biggest problems. We talked to them about the wealth tax, Medicare for All, and some huge misunderstandings about migration. | Business Insider | 11/13/2019

The MIT economists Abhijit Banerjee and Esther Duflo have been at the forefront of rethinking the way we tackle extreme poverty. Their approach of using randomized control trials, typically used by clinical researchers, can sound deceptively simple, but it was groundbreaking enough to win them the 2019 Nobel Memorial Prize in Economic Sciences , which they shared with Harvard’s Michael Kremer. Now they’re taking the approach that has helped improve the …

eClinical Solutions to Sponsor and Speak at Medidata NEXT NYC Conference | 11/13/2019

eClinical to lend clinical data management expertise in leading event on technology innovations in the life sciences industry. BOSTON eClinical Solutions LLC , a leading global provider of cloud-based products for clinical research and software-driven clinical data services, today announced their sponsorship of Medidata NEXT global conference on life science technology innovation. Medidata NEXT NYC will be held November 12-13 at Spring Studios in New York City. The patient …

OptiNose, Inc. (OPTN) Q3 2019 Earnings Call Transcript | The Motley Fool | 11/13/2019

… next task – to the next key task in the product messaging latter, achieving a perception of differentiated clinical outcomes. We knew that the next step will require a sustained promotional focus, bolstered by good clinical research data plus physician experience using the product enrolled patients, plus increasing awareness and discussion by peers in the specialist community. We recently completed a follow-up market research survey of target physicians to check …

Association between Aspartate Aminotransferase-to-Platelet Ratio Index and Hepatocellular Carcinoma Risk in Patients with Chronic Hepatitis: A Meta-Analysis of Cohort Study | 11/13/2019

… Aminotransferase-to-Platelet Ratio Index and Hepatocellular Carcinoma Risk in Patients with Chronic Hepatitis: A Meta-Analysis of Cohort Study 1 Department of Central Laboratory, Taizhou People’s Hospital, Taizhou, 225300 Jiangsu Province, China 2 Clinical Research Center, The Affiliated Hospital of Guangdong Medical University, Zhanjiang, 524001 Guangdong Province, China 3 Clinical Laboratory, Taizhou People’s Hospital, Taizhou, 225300 Jiangsu Province, China 4 Department of Infectious Disease, Taizhou People’s Hospital, Taizhou, 225300 …

(USA-MD-Baltimore) Research Assistant | 11/13/2019

… over time. Specific Duties & Responsibilities: Maintain a good working knowledge of all assigned protocols and reporting requirements; Run routine and ad hoc reports from databases; Adhere to all protocol requirements to ensure validity of clinical research data; Interact with clinicians and other gatekeepers to access the patient population; Recruit research participants; Verify patient eligibility for studies; Interview patients; Collect patient specimens (e.g., blood draws, urine, or saliva) and other patient …

Conflict of Interest Statements Don’t Affect Peer Review | 11/13/2019

Print Most scientific and clinical research journals require authors to disclose potential conflicts of interest (COI) as a condition of submitting a manuscript for peer review. But a new study by researchers at UC San Francisco, Carnegie Mellon University, and Harvard Business School reveals that peer reviewers do not take COI disclosures into account in their recommendations to journal editors, likely because of an absence of clear guidelines on how …

National Institutes of Health

First-ever majority women lead ATA Board of Directors: | 11/14/2019

… all! Martha Zeiger, MD, President Dr. Martha A. Zeiger is the Director of Surgical Oncology at the National Cancer Institute, National Institutes of Health. Regarded as a world leader in endocrine surgery, she is also … completed her medical degree, residency, and fellowship training. As a clinical researcher in the thyroid field, her time is divided between research, clinical activities, and teaching. Dr. Jonklaas’s research has focused on the management of …

What will Clinical Research Look Like in 5, 10, 20 Years? Are We Heading to Heaven, Hell or Purgatory? Part 2 of 4 - Saama Technologies | 11/13/2019

… equally adept at shaping strategy and driving execution as well as nurturing culture. Jay held the position of SVP, Global Clinical Research & Development Operations at Celgene Corporation and was responsible for leading all Global Clinical … experience in clinical research, including positions with academia, the U.S. National Institutes of Health, a global CRO and biopharmaceutical companies in the U.S. and Japan. She wrote the chapter on Data Sharing in Clinical Research

Regenerative Medicine

Global Regenerative Medicine Market to Grow Over $81 Billion by 2023 and Market Driven by Stem Cells, Tissue Engineering, BioBanking & CAR-T Industries - ReportsnReports | PR Newswire | 11/13/2019

PUNE, India This report provides a comprehensive overview of the size of the regenerative medicine market, segmentation of the market (stem cells, tissue engineering and CAR-T therapy), key players and the vast potential of … also the level of investment required to support R&D, clinical research, trials and commercialization. Reimbursement strategies are also paramount to success of the overall space. There are over 700 regenerative medicine companies globally at …

Gerstner Regenerative Medicine Initiative: Tracking outcomes and supporting clinical trials | 11/12/2019

Gerstner Regenerative Medicine Initiative: Tracking outcomes and supporting clinical trials By Jennifer Schutz Outcomes registry tablet used during consults. One of the challenges of integrating regenerative medicine into daily patient care is that it is … also using this information to inform patients about regenerative options. “Clinical research trials are tightly controlled and often start with small patient numbers which will exclude a larger representation of our patient population,” says Dr …

Digital Health

AMRA Medical Abstract Selected for AASLD’s “Best of The Liver Meeting” Showcase | PR Newswire | 11/13/2019

… following The Liver Meeting 2019 in Boston . AMRA Medical is dedicated to supporting transformative care and vital decision-making from clinical research to health and wellness; AASLD highlighting this research is an honor that will … glz229 . About AMRA Medical AMRA ( www.amramedical.com ) is a groundbreaking international digital health company at the forefront of medical imaging and precision medicine. The company has developed a new global standard in body composition assessment, the …

Introducing the TC Top Picks for Disrupt Berlin 2019 – TechCrunch | 11/12/2019

… clinical research. Healthy Quit : Digital health company and a pharmacy that provides vaping and smoking cessation by utilizing an artificial intelligent treatment algorithm and medications to help patients quit. mettleAI : Leveraging ML/AI to predict substance abuse relapse before it happens. Thryve : We power the individualization of health care by providing the API needed by health services to access health data from more than 100 wearables. Volta Medical : Aims at …

Population Health

Javara And Privia Health Align To Integrate Clinical Trials Into The Patient Care Continuum | PR Newswire | 11/13/2019

… time data allows us to match the right care to the right patient including the high touch options provided by clinical research,” said Keith Fernandez , MD, Privia Health’s Chief Clinical Officer. Javara provides resources and … experience. Through high-performance physician groups, accountable care organizations, and population health management programs, Privia works in partnership with health plans, health systems and employers to better align reimbursements to quality and outcomes. Our physician …

Javara And Privia Health Align To Integrate Clinical Trials Into The Patient Care Continuum | BioSpace | 11/13/2019

… time data allows us to match the right care to the right patient including the high touch options provided by clinical research,” said Keith Fernandez , MD, Privia Health’s Chief Clinical Officer. Javara provides resources and … experience. Through high-performance physician groups, accountable care organizations, and population health management programs, Privia works in partnership with health plans, health systems and employers to better align reimbursements to quality and outcomes. Our physician …

CDC

Clinical Research Coordinator - Eugene | 11/12/2019

… Job Description Willamette Valley Cancer Institute and Research Center, located in Eugene, has an exciting opportunity for a Non-RN Clinical Research Coordinators . Under direct supervision of a physician and nurse (if applicable), our CRCs … and professional regulatory standards as issued through OSHA and the CDC. Maintains strict patient confidentiality according to HIPAA regulations and applicable law. QUALIFICATIONS: Experience and Education: Bachelor’s degree in a clinical or scientific related discipline …

Newly Published Research Demonstrates Ability of Hologic’s Assay to Detect Mycoplasma Genitalium, “the Silent Epidemic” | Business Wire | 11/11/2019

… and in 2015 was listed as an emerging public health issue by the U.S. Centers for Disease Control and Prevention (CDC). 2,3 Current estimates indicate that M. genitalium may affect more than 15 percent of … 2017 and April 2018. Subjects were enrolled at STI clinics, clinical research centers, and emergency medicine, family planning, public health, STI and family medicine/obstetric-gynecologic sites. The study evaluated prevalence, sensitivity, specificity, positive predictive …

Clinical Data

Head-To-Head Survey: OmniComm Systems (OTCMKTS:OMCM) & Phreesia (OTCMKTS:PHR) | 11/11/2019

… healthcare technology company, provides Web-based electronic data capture (EDC), and eClinical software and services for pharmaceutical and biotechnology companies, clinical research organizations (CROs), and other clinical trial sponsors worldwide. It offers TrialMaster, which allows … that comprises a set of tools for collecting and managing clinical data, including EDC for real-time entry and double data entry (DDE) for entry from paper originals; and Promasys, a clinical trial data management …

Prevalence and Associated Factors of Metabolic Syndrome among Patients with Severe Mental Illness Attending a Tertiary Hospital in Southwest Uganda | 11/11/2019

… diagnosis, type of psychotropic medication, and duration on psychotropic medication. The outcome variable was metabolic syndrome. 2.1. Measurements Sociodemographic and clinical data were captured using a structured questionnaire. We determined the level of physical activity … in the metabolic syndrome and their role for cardiovascular disease,” Clinical Research in Cardiology , vol. 95, no. 3, pp. 136–147, 2006. View at Publisher · View at Google Scholar · View at Scopus F. D. Alosaimi …

Precision Medicine

Lung and Gut Microbiota as Potential Hidden Driver of Immunotherapy Efficacy in Lung Cancer | 11/11/2019

… diet and eating habits. These variables are closely related to geographical location, suggesting therefore the need of more in-depth clinical research studies, looking at ethnic diversity as well as eating habits and environment-related … metabolite regulation of host defenses at mucosal surfaces: implication in precision medicine,” Precision Clinical Medicine , vol. 2, no. 2, pp. 110–119, 2019. View at Publisher · View at Google Scholar M. Sun, W. Wu, L …

Global Clinical Study Sponsors and Clinical Research Organizations Gather for the “Era of Life Science Transformation” at Medidata NEXT NYC 2019 | Business Wire | 11/11/2019

… risk-based monitoring, and launch readiness. Medidata customers and partners, including senior executives and experts from global study sponsors and clinical research organizations (CROs), will lead more than 80 percent of these sessions. Medidata NEXT … Medidata Medidata is The Operating System for Life Sciences™ and precision medicine. Medidata helps pharmaceutical, biotech, medical device and diagnostics companies, and academic researchers accelerate value, minimize risk, and optimize outcomes. More than one million …

Clinical Operations

Deal-hungry WCG snaps up trial management consultancy Waife & Associates | FierceBiotech | 11/11/2019

… focuses on making clinical development more efficient and productive by managing areas in organization, process and technology, with services including: clinical operations process improvement, information technology strategy and implementation management, service/product vendor selection and … the operations of those who sponsor and conduct life-saving clinical research.” RELATED: WIRB-Copernicus Group boosts executives, global network This comes several months after WCG snapped up PharmaSeek, which specializes in consulting, patient recruitment …

Global Clinical Study Sponsors and Clinical Research Organizations Gather for the “Era of Life Science Transformation” at Medidata NEXT NYC 2019 | Business Wire | 11/11/2019

… risk-based monitoring, and launch readiness. Medidata customers and partners, including senior executives and experts from global study sponsors and clinical research organizations (CROs), will lead more than 80 percent of these sessions. Medidata NEXT … and attracts over 3,000 leaders in drug and device development, clinical operations, data management, biostatistics, and digital medicine innovation industries. These professionals gather for networking and learning across six Medidata NEXT conferences in Basel, London …

National Cancer Institute

Wake Forest Baptist receives $6M grant toward pain management study for cancer patients | 11/11/2019

Wake Forest Baptist Medical Center is the recipient of a $6 million grant from the National Cancer Institute to test the effectiveness of a web-based pain-management program. The goal is to develop a … Forest Baptist in 2014. The latest grant focuses on extending clinical research in cardiovascular and neurocognitive complications of cancer treatments, and on improving patient well-being during cancer care. Dr. Glenn Lesser, an oncology professor …

Promega and Merck collaborate to develop MSI companion diagnostic for use with anti-PD-1 therapy | 11/8/2019

… cells. Unlike other DNA-based molecular screening options, Promega MSI technology uses five monomorphic mononucleotides, which is recommended by the National Cancer Institute. Our test uses a sensitive and specific panel of markers for detection … Administration (NMPA) in China. It has been used extensively in clinical research for more than 15 years and is supported by more than 140 peer-reviewed publications. Promega continues to advance the promise of MSI …

Patient Engagement

Global Clinical Study Sponsors and Clinical Research Organizations Gather for the “Era of Life Science Transformation” at Medidata NEXT NYC 2019 | Business Wire | 11/11/2019

… patient engagement, risk-based monitoring, and launch readiness. Medidata customers and partners, including senior executives and experts from global study sponsors and clinical research organizations (CROs), will lead more than 80 percent of these sessions. Medidata NEXT NYC will also host a one-day hackathon, Real Patients, Virtual Trials , to inspire innovation around patient-centric clinical trials . The hackathon will help spur innovators to create novel mobile applications, using the …

Signant Health Proud to Sponsor the Philadelphia Walk to End Alzheimer’s in Nationwide Effort to Build Awareness, Raise Funds and Advance Research Towards a Cure | BioSpace | 11/11/2019

… Patient Engagement, IRT, Clinical Supplies and Endpoint Quality into the industry’s most comprehensive patient-centric suite – an evolution built on more than 20 years of proven clinical research technology. Our intense focus on the patient experience, deep therapeutic area expertise and global operational scale enable hundreds of sponsors and CROs (including all Top 20 pharma) to extend the reach of drug development, expand patient opportunities and improve data quality – helping …

Merck

The Predictive Approaches to Treatment effect Heterogeneity (PATH) Statement | 11/12/2019

… Information This article was published at Annals.org on 12 November 2019. Predictive Analytics and Comparative Effectiveness (PACE) Center, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, Massachusetts (D.M.K., J.K.P., J.B.W.) Erasmus … the submitted work; and personal fees from Boehringer Ingelheim and Merck outside the submitted work. Dr. Ross reports personal fees from PCORI during the conduct of the study and grants from the U.S. Food and …

A High Level of Circulating Valine Is a Biomarker for Type 2 Diabetes and Associated with the Hypoglycemic Effect of Sitagliptin | 11/11/2019

… randomized into two groups: one group was treated with sitagliptin (Sit; ), and the other group was treated with placebo ( ). Sit (Merck Sharp & Dohme, USA) was administered at a dose of 100 mg/d. Moreover, all … 2016YFC1101100), the Natural Science Foundation of Chongqing (no. cstc2016jcyjA0093), the Clinical Research Project of Xinqiao Hospital of Third Military Medical University (no. 2016YLC20 to H.Q.), and the Miaopu Cultivation Project of Army Medical University (to …

Gilead Sciences

New data on filgotinib in rheumatoid arthritis demonstrate durable efficacy and safety | 11/12/2019

Foster City, Calif., and Mechelen, Belgium. Gilead Sciences, Inc. (Nasdaq: GILD) and Galapagos NV (Euronext & NASDAQ: GLPG) today announced detailed results from the companies’ clinical research program evaluating filgotinib, an investigational, oral, selective JAK1 inhibitor, in adults with moderately-to-severely active RA. The data demonstrate durable efficacy and safety results with filgotinib across multiple RA patient populations, from MTX-naïve patients to those who have had an inadequate response …

TG Therapeutics Could Be About To Deliver On Rich Promise - TG Therapeutics, Inc. (NASDAQ:TGTX) | Seeking Alpha | 11/11/2019

… Gilead Sciences) and duvelisib (sold under brand name Copiktra , manufactured by Verastem Oncology), umbrasilib has arguably performed best in clinical trials. Reviewing results of the phase II UNITY-NHL trial, presenting author Nathan H. Fowler, MD, Associate Professor of Medicine and Director of Clinical Research in the Department of Lymphoma/Myeloma at The University of Texas MD Anderson Cancer Center, Houston, commented: The adverse event and clinical activity data are …

Medtronic

The Predictive Approaches to Treatment effect Heterogeneity (PATH) Statement | 11/12/2019

… Information This article was published at Annals.org on 12 November 2019. Predictive Analytics and Comparative Effectiveness (PACE) Center, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, Massachusetts (D.M.K., J.K.P., J.B.W.) Erasmus … study and grants from the U.S. Food and Drug Administration, Medtronic, Johnson & Johnson, the Centers for Medicare & Medicaid Services, Blue Cross Blue Shield Association, the Agency for Healthcare Research and Quality, the National Institutes of …

PCI vs CABG in Left Main Disease – The Surgeons Are Right | Medscape | 11/8/2019

… second author, surgeon Arie Pieter Kappetein, MD, PhD, originally from Erasmus University Medical Center in the Netherlands, but now at Medtronic, denied Taggart’s claim that endpoints were changed. I will not wade into the accusations … espouses a conservative approach to medical practice. He participates in clinical research and writes often about the state of medical evidence …

IQVIA

Selonsertib misses endpoint, provides future trial design insight | 11/11/2019

… to see what we can glean from a study of this magnitude,” Stephen A. Harrison, MD, medical director of Pinnacle Clinical Research in San Antonio, said during his presentation. “Data from these trials provide important … Corcept, CymaBay, Echosens, Galectin, Galmed, Gilead, HighTide, HistoIndex, Innovate, Intercept, IQVIA, Lipocine, Madrigal, Medpace, Metacrine, NGM, Novartis, Novo Nordisk, Perspectum, Pfizer, Poxel, PPD, Prometheus, Prometic and Terns; is on the speakers bureau with Alexion; and …

Contract Research Organization (CRO) Market to Witness Massive Growth During the Forecast Period 2019-2025 | 11/11/2019

… registration for the clinical trials. Avail Discount on the Report at - https://www.theinsightpartners.com/discount/TIPBT00002008/ Type Insights In 2017, the clinical research services segment held a largest market share of 54.4% of the contract research … Corporation of America Holdings’s drug development business. 2018: In June, IQVIA launched Virtual Research Solutions, a new suite of technology-led study options offering advances in patient-centric trial design and execution. Powered by the …

Pfizer

Lung and Gut Microbiota as Potential Hidden Driver of Immunotherapy Efficacy in Lung Cancer | 11/11/2019

… diet and eating habits. These variables are closely related to geographical location, suggesting therefore the need of more in-depth clinical research studies, looking at ethnic diversity as well as eating habits and environment-related … received honoraria or speakers’ fee from MSD, Astra-Zeneca, Celgene, Pfizer, Helsinn, Eli-Lilly, BMS, Novartis, and Roche; E.B. also received research grants from I.A.S.L.C. (International Association for the Study of Lung Cancer), L.I.L.T. (Lega …

Selonsertib misses endpoint, provides future trial design insight | 11/11/2019

… to see what we can glean from a study of this magnitude,” Stephen A. Harrison, MD, medical director of Pinnacle Clinical Research in San Antonio, said during his presentation. “Data from these trials provide important … IQVIA, Lipocine, Madrigal, Medpace, Metacrine, NGM, Novartis, Novo Nordisk, Perspectum, Pfizer, Poxel, PPD, Prometheus, Prometic and Terns; is on the speakers bureau with Alexion; and has received research support from Allergan, Axcella, Cirius, Conatus, CymaBay …

Novartis

Lung and Gut Microbiota as Potential Hidden Driver of Immunotherapy Efficacy in Lung Cancer | 11/11/2019

… diet and eating habits. These variables are closely related to geographical location, suggesting therefore the need of more in-depth clinical research studies, looking at ethnic diversity as well as eating habits and environment-related … from MSD, Astra-Zeneca, Celgene, Pfizer, Helsinn, Eli-Lilly, BMS, Novartis, and Roche; E.B. also received research grants from I.A.S.L.C. (International Association for the Study of Lung Cancer), L.I.L.T. (Lega Italiana per la Lotta contro …

Selonsertib misses endpoint, provides future trial design insight | 11/11/2019

… to see what we can glean from a study of this magnitude,” Stephen A. Harrison, MD, medical director of Pinnacle Clinical Research in San Antonio, said during his presentation. “Data from these trials provide important … HighTide, HistoIndex, Innovate, Intercept, IQVIA, Lipocine, Madrigal, Medpace, Metacrine, NGM, Novartis, Novo Nordisk, Perspectum, Pfizer, Poxel, PPD, Prometheus, Prometic and Terns; is on the speakers bureau with Alexion; and has received research support from Allergan …

AbbVie

TG Therapeutics Could Be About To Deliver On Rich Promise - TG Therapeutics, Inc. (NASDAQ:TGTX) | Seeking Alpha | 11/11/2019

… of the phase II UNITY-NHL trial, presenting author Nathan H. Fowler, MD, Associate Professor of Medicine and Director of Clinical Research in the Department of Lymphoma/Myeloma at The University of Texas MD Anderson … is marketed under the brand name Imbruvica™ by pharma giant AbbVie, which also sells the CLL chemotherapy drug Venclexta. In 2018 AbbVie reported hematologic oncology product sales of $3.21 billion in the US market; a …

Live zoster vaccine safe, effective in patients taking TNF inhibitors | 11/11/2019

… very excited about the results of this long-planned and long in coming study,” Jeffrey Curtis , MD, a rheumatologist and clinical researcher at the University of Alabama at Birmingham, and Healio Rheumatology Peer Perspective Board … 24.5%), and the most common agents used were adalimumab (Humira, Abbvie; 32.7%), infliximab (Remicade, Janssen; 31.3%), etanercept (Enbrel, Amgen; 21.2%), golimumab (Simponi, Janssen; 9.1%) and certolizumab (Cimzia, UCB; 5.7%). Half of patients were assigned to …

Thermo Fisher

Cerebroprotective Effect against Cerebral Ischemia of the Combined Extract of Oryza sativa and Anethum graveolens in Metabolic Syndrome Rats | 11/11/2019

… min. The supernatant was kept, and the protein concentration was also measured by using a Thermo Scientific NanoDrop 2000c spectrophotometer (Thermo Fisher Scientific, Wilmington, Delaware, USA). 2.12. Biochemical Assessments 2.12.1. Oxidative Stress Marker Assessment The … and amelioration by vitamin E,” Asian Journal of Pharmaceutical and Clinical Research , vol. 4, no. 2, pp. 164–167, 2011. View at Google Scholar S. A. Goldblith and B. E. Proctor, “Photometric determination of catalase …

Capillary Electrophoresis Market to Witness Significant Rise in Revenue During the Forecast Period 2018 - 2025 | 11/10/2019

… advantages of the system include high accuracy, efficiency and higher reproducibility. This electrophoresis technique is widely used in biosciences and clinical research. Get Sample Copy Of The [email protected] https://www.trendsmarketresearch.com/report/sample/3944 Growth by … wide range of molecules for USD 250 million in cash. Thermo Fisher Scientific, an American biotechnology product development company had launched its new capillary electrophoresis (CE) system which is designed to offer a low-throughput …

Allergan

Selonsertib misses endpoint, provides future trial design insight | 11/11/2019

… to see what we can glean from a study of this magnitude,” Stephen A. Harrison, MD, medical director of Pinnacle Clinical Research in San Antonio, said during his presentation. “Data from these trials provide important … speakers bureau with Alexion; and has received research support from Allergan, Axcella, Cirius, Conatus, CymaBay, Galectin, Galmed, Genfit, Gilead, HighTide, Immuron, Intercept, Madrigal, NGM, Novartis, Novo Nordisk, Pfizer, Second Genome and Tobira. This study was …

What’s in a name? Ghostly spirits stalk the medical literature | 11/10/2019

… Jon Jureidini, are nearing publication of a book entitled, “The Illusion of Evidence-Based Medicine: Examining the Scientific Foundation of Clinical Research.” Author ”TBD” In recent years, hundreds of internal documents about drug industry publishing … In 2009, the Justice Department charged Forest , now part of Allergan, with fraudulent marketing practices, citing, among other things, an allegedly misleading article drafted by a contract medical writer, and kickbacks paid to doctors. Forest …

Celgene

Lung and Gut Microbiota as Potential Hidden Driver of Immunotherapy Efficacy in Lung Cancer | 11/11/2019

… diet and eating habits. These variables are closely related to geographical location, suggesting therefore the need of more in-depth clinical research studies, looking at ethnic diversity as well as eating habits and environment-related … E.B. received honoraria or speakers’ fee from MSD, Astra-Zeneca, Celgene, Pfizer, Helsinn, Eli-Lilly, BMS, Novartis, and Roche; E.B. also received research grants from I.A.S.L.C. (International Association for the Study of Lung Cancer), L.I.L.T …

(NLD-Utrecht) Medical Advisor | 11/10/2019

Job Information Celgene Medical Advisor in Utrecht , Netherlands Celgene is a global biopharmaceutical company committed to changing the course of human health through bold pursuits in science, life-enhancing therapies, and a promise to always … Health Care decision making. Knowledge of methodology and regulations in Clinical Research and some experience in operational aspects of Clinical Research. Excellent communication verbal and written in Dutch and English. Willingness to travel; possesses valid …

Morgan Stanley

What will Clinical Research Look Like in 5, 10, 20 Years? Are We Heading to Heaven, Hell or Purgatory? Part 2 of 4 - Saama Technologies | 11/13/2019

… equally adept at shaping strategy and driving execution as well as nurturing culture. Jay held the position of SVP, Global Clinical Research & Development Operations at Celgene Corporation and was responsible for leading all Global Clinical … Before working for Goldman Sachs, he was an associate at Morgan Stanley, where he worked in the Telecom/Media Mergers & Acquisitions Group. Marc earned his MBA with a concentration in finance and accounting from The …

Anna Penn, MD, PhD, to Lead Neonatology at Columbia University Irving Medical Center and NewYork-Presbyterian Morgan Stanley Children’s Hospital | PR Newswire | 11/12/2019

Anna Penn, MD, PhD, to Lead Neonatology at Columbia University Irving Medical Center and NewYork-Presbyterian Morgan Stanley Children’s Hospital News provided by Columbia University Irving Medical Center Nov 12, 2019, 11:47 ET NEW YORK … Irving Medical Center provides international leadership in basic, preclinical, and clinical research; medical and health sciences education; and patient care. The medical center trains future leaders and includes the dedicated work of many physicians, scientists …

Abingworth

Avillion Appoints Dr Anders Gersel Pedersen, M.D., Ph.D. as Board Member | PR Newswire | 9/5/2019

… clinical research, development, regulatory affairs and product life cycle management. He is the former Executive Vice President of Research & Development of H. Lundbeck A/S. Dr Pedersen will join Kurt Wheeler (Blackstone), Jim Reddoch (Royalty Pharma), Genghis Lloyd-Harris (Abingworth), Ted Love (Independent) and David Chiswell (Independent) as a Non-Executive Director on the Board of Directors of Bond 2 Development 2 GP Limited. Avillion LLP provides R&D services …

VC-backed VenatoRx beefs up team with three new hires | PE Hub | 8/21/2019

… medical sciences; and Lauren P. Tornetta has been appointed vice president of regulatory affairs. VenatoRx is backed by Versant Ventures, Abingworth and Foresite Capital. PRESS RELEASE MALVERN, Pa.–(BUSINESS WIRE)–VenatoRx Pharmaceuticals today announced the … Clinical & Medical Affairs at Paratek Pharmaceuticals; Senior Director at Actelion Clinical Research; and Director of Vaccine Research and Clinical Affairs for Infectious Diseases at Wyeth/Pfizer. Dr. McGovern received his B.S. from the University of …

SunTrust Robinson Humphrey

Deciphera Pharmaceuticals Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares in Public Offering of Common Stock | 9/3/2019

SunTrust Robinson Humphrey acted as co-manager for the offering. Deciphera intends to use the net proceeds of the offering to fund: clinical trials for ripretinib, including the expansion stage of its current Phase 1 clinical trial, its ongoing pivotal Phase 3 clinical trials, and additional clinical trials, as well as clinical research outsourcing and manufacturing of clinical trial material, and pre-commercialization manufacturing process development and validation; clinical trials …

Massachusetts General Hospital

Head-To-Head Survey: Fluoropharma Medical (OTCMKTS:FPMI) & Heska (OTCMKTS:HSKA) | 11/11/2019

Massachusetts General Hospital and Sinotau USA; and clinical research agreements with Pharmaceutical Product Development, LLC, as well as Cardiovascular Imaging Technologies. FluoroPharma Medical, Inc. was founded in 2003 and is headquartered in Montclair, New Jersey. About Heska Heska Corporation manufactures, sells, and markets veterinary diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Europe, and internationally. The company’s Core Companion Animal segment offers Element …

Letter: Efforts underway on many fronts to help our country’s volunteer force | 11/10/2019

… clinical research being done at some major medical centers here, such as Massachusetts General Hospital. Project Home Base, an initiative sponsored by the Boston Red Sox and Massachusetts General Hospital, has proven that PTSD, even very severe cases of it, can be effectively treated. The Massachusetts Legislature is partnering with them. We have provided $1.3 million to Home Base and are working with them to extend their world-class care …

Harvard Medical School

An ODD Diagnosis Doesn’t Make Your Child “Bad” | 11/11/2019

… clinical researcher at Boston Children’s Hospital, therapist in private practice, and holds faculty appointments at Harvard Medical School, University of New Hampshire and Simmons School of Social Work. She is also a mom. Mightier uses the power of bioresponsive games to help kids build and practice calming skills to meet real-world challenges. White, E. (2019). An ODD Diagnosis Doesn’t Make Your Child “Bad”. //psychcentral.com/blog/an-odd-diagnosis-doesnt …

Katharine McCormick’s Crusade | 11/10/2019

… G. Hoskins and the possible role of defective adrenal glands in mental illness, she established the Neuroendocrine Research Foundation at Harvard Medical School and funded the publication of the journal Endocrinology . With Stanley’s death on … of the estimated two million dollars that went into the clinical research and subsequent trials came from her. Pincus and his associate, John Rock, could not do open research using hormones for contraception (which was …

Mayo Clinic

Fibrinogen-to-Albumin Ratio Predicts Contrast-Induced Nephropathy in Patients after Emergency Percutaneous Coronary Intervention | 11/11/2019

… costs, as well as prolong hospitalization [ 20 , 21 ]. The incidence of CIN was 3.3% in the interventional cardiology registry from Mayo Clinic including 7586 patients [ 22 ]. However, the incidence of CIN rises dramatically in patients … of this study are restricted by the Fujian Provincial Hospital Clinical Research Ethics Committee in order to protect patient privacy. Data are available from the corresponding author ([email protected]) for researchers who meet the criteria …

American College of Rheumatology Announces 2019 Award Recipients | 11/9/2019

… to a young physician scientist, age 45 or younger, who has made outstanding and promising independent contributions to basic or clinical research in the field of rheumatology. Distinguished Clinical Investigator Award: Susan Manzi, MD, MPH … University School of Medicine, Baltimore, MD Ali Duarte-Garcia, MD , Mayo Clinic, Rochester, MN Rebecca Haberman, MD , NYU Langone Health, New York, NY Jean W. Liew, MD , University of Washington, Seattle, WA Mazen Nasrallah MD …

Kaiser Permanente

Kaiser Permanente mourns the loss of Bernard J. Tyson, Chairman and CEO | Yahoo News | 11/11/2019

… Nov. 10, 2019 /PRNewswire/ – It is with profound sadness that we announce that Bernard J. Tyson , Chairman and CEO of Kaiser Permanente, unexpectedly passed away early today in his sleep. On behalf of our Board … chronic disease management. Kaiser Permanente is dedicated to care innovations, clinical research, health education and the support of community health. https://about.kaiserpermanente.org/ Contact Darryl Ryan [email protected] (510) 406-4925 John Nelson [email protected] 510-435-3185 Kaiser …

Kaiser Permanente Mourns Death of Chairman, CEO Bernard J. Tyson | 11/11/2019

Bernard J. Tyson, Kaiser Permanente chairman and CEO, died in his sleep early Sunday. He was 60. Kaiser Permanente issued the following statement Sunday: “On behalf of our Board of Directors, employees and physicians, we … chronic disease management. Kaiser Permanente is dedicated to care innovations, clinical research, health education and the support of community health. Visit https://about.kaiserpermanente.org/ . Share this story …

HCA

Clinical Research Nurse - Denver, CO, , USA #jobs #Denver pls RT | 11/6/2019

Job Detail for Clinical Research Nurse Job Location: CareerBliss, Denver, CO, Clinical Research Nurse Job Location: CareerBliss, Denver, CO, , USA Jobs In Clinical Research Nu Denver Jobs In Clinical Resea… Jobs In Clinical … Description SHIFT: No Weekends SCHEDULE: Full-time HCA Research Institute’s Cardiovascular Research has conducted over 180 industry-sponsored trials and enrolled more than 2,000 patients since the program’s inception providing innovative approaches to clinical trial management. Since …

ASCO President’s Thoughts on Conquering Cancer: Unite : Oncology Times | 11/5/2019

… Howard “Skip” Burris III, MD, FACP, FASCO, is President and Chief Medical Officer for Sarah Cannon, the Cancer Institute of HCA Healthcare, in Nashville, and current President of the American Society of Clinical Oncology (ASCO … eradicate their cancer was the beginning of my practice and clinical research. “Patients were coming to us for another idea, another option, and another alternative. While they presented a diverse group of cancers, they comprised …

UPMC

Internationally Recognized UPMC Cancer Surgeon Joins Allegheny Health Network as Cancer Institute Chair | PRWeb | 11/6/2019

Internationally Recognized UPMC Cancer Surgeon Joins Allegheny Health Network as Cancer Institute Chair Share Article David L. Bartlett, MD, an internationally recognized cancer researcher and a pioneer in the use of highly advanced surgical therapies … Sloan-Kettering Cancer Center in New York. He also performed clinical research at MD Anderson Cancer Center in Houston. Dr. Bartlett specializes in all aspects of surgical oncology, with expertise in peritoneal surface malignancies, the …

Mount Sinai Health System

FDA Approves Clinical Trial of a New Treatment Approach for Enlarged Prostate | 11/5/2019

… technologies,” said Dr. Steven Kaplan, professor, Icahn School of Medicine at Mount Sinai and director of the Men’s Wellness Program, Mount Sinai Health System in New York, N.Y., and the principal investigator of PINNACLE. “This … Raleigh; AUUA (Academic Urology & Urogynecology of Arizona), Phoenix; Carolina Urology Clinical Research (CUCR), Myrtle Beach, S.C.; Carolina Urology Partners, Charlotte, N.C.; Mount Sinai, New York, N.Y.; Urology of Virginia, Norfolk, Va.; Chesapeake 2, Baltimore; and …

Mount Sinai Health System Launches New Precision Wellness ‘N1’ App | PRWeb | 11/4/2019

Mount Sinai Health System Launches New Precision Wellness ‘N1’ App Share Article A medical science tool for individuals to compare the effectiveness of wellness-related treatments NEW YORK Have you ever wondered whether your double … error can be challenging. “We’ve taken the tools that power clinical research and for the first time made them available to the public,” says Noah Zimmerman, PhD, founding Director of the Health Data and Design …

Sinai Health System

Cidara Therapeutics Hosting Key Opinion Leader Meeting on Rezafungin and Cloudbreak Programs | Globe Newswire | 11/5/2019

… Society for Clinical Investigators (ASCI) and the Association of American Physicians (AAP) and is known worldwide for her translational and clinical research focused on diagnostics and treatment of invasive fungal infections. Her research has led … Clinician Scientist at the Lunenfeld-Tanenbaum Research Institute of the Sinai Health System in Toronto. Her research interests are in the use of epidemiology to reduce the burden of infectious diseases and antimicrobial resistance in …

Cidara Therapeutics Hosting Key Opinion Leader Meeting on Rezafungin and Cloudbreak Programs - GuruFocus.com | 11/5/2019

… Society for Clinical Investigators (ASCI) and the Association of American Physicians (AAP) and is known worldwide for her translational and clinical research focused on diagnostics and treatment of invasive fungal infections. Her research has led … Clinician Scientist at the Lunenfeld-Tanenbaum Research Institute of the Sinai Health System in Toronto. Her research interests are in the use of epidemiology to reduce the burden of infectious diseases and antimicrobial resistance in …

Cleveland Clinic

EMBASE Cardiac Update AutoAlert: EPICORE Cardiac Surgery Blogger2 | 11/3/2019

… Department, Rasool Akram Hospital, Iran University of Medical Sciences, Tehran, Iran, Islamic Republic of (Ghiasi, Gorabi) Department of Basic and Clinical Research, Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran, Islamic Republic of … Centre Mainz, Mainz, Germany (Cremer, Jaber) Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH, United States (Celermajer) Faculty of Medicine and Health, University of Sydney, New South Wales, Australia (Kaye) Department of Cardiology, Alfred Hospital …

MEDNAX Expands Presence in Florida through Affiliation with Leading Pediatric Plastic Surgery Practice on Stocks News Feed | 11/3/2019

… and the Virgin Islands as well as 13 regional hospitals and five outpatient centers. The practice holds teaching relationships with Cleveland Clinic Florida, Barry University and Nova University. “The MEDNAX national network provides a great … specialties and subspecialties, using evidence-based tools, continuous quality initiatives, clinical research and telemedicine to enhance patient outcomes and provide high-quality, cost-effective care. The Company was founded in 1979, and today, through its …

MD Anderson Cancer Center

Veracyte Announces New Data That Advance Understanding of Genomic Alterations Targeted by Precision Medicine Therapies for Thyroid Cancer | Business Wire | 11/2/2019

… included selective inhibitors of ALK, BRAF, NTRK and RET , which makes their detection in patients with thyroid cancer of interest to physicians,” said Mimi I. Hu, M.D., professor at The University of Texas MD Anderson Cancer Center, who presented the findings in a poster. “As our understanding of the role of genomics in thyroid cancer advances, this information offers the potential to optimize initial treatment, predict response to treatment and …

Health Net

St. Joseph Hospital Joins Caris Life Sciences’ Precision Oncology Alliance | PR Newswire | 10/30/2019

… precision medicine.” The Precision Oncology Alliance comprises 30 academic, hospital and community-based cancer institutions, including eight National Cancer Institute (NCI)-designated Comprehensive Cancer Centers. “End-to-end cancer care and leading-edge clinical research are hallmarks of St. Joseph Hospital, and we welcome them to the Precision Oncology Alliance as we continue to change the way the disease is managed through precision medicine,” said W. Michael Korn , M.D. , Chief …

Spectrum Therapeutics and Tree of Knowledge Announce Partnership to Educate and Support Healthcare Professionals | PR Newswire | 10/30/2019

… site and country at a time. Canopy Growth has operations in over a dozen countries across five continents. Canopy Growth’s medical division, Spectrum Therapeutics is proudly dedicated to educating healthcare practitioners, conducting robust clinical research, and furthering the public’s understanding of cannabis, and has devoted millions of dollars toward cutting edge, commercializable research and IP development. Spectrum Therapeutics sells a range of full-spectrum products using its colour-coded classification …

Aetna

What’s in the Offing for LabCorp’s (LH) Earnings in Q3? | MSN | 10/21/2019

… of 2019, banking on the following facts: First, in 2019, the company officially collaborated with Horizon, NJ-based UnitedHealthcare and Aetna, placing LabCorp in-network under all major national plans. Ever since, the company has … third quarter. The transaction provides Covance with better global non-clinical research capabilities while sustaining access to bigger research models and services through a multi-year renewable supply agreement. For 2019, on an overall basis …

What’s in the Offing for LabCorp’s (LH) Earnings in Q3? - October 21, 2019 - Zacks.com | 10/21/2019

… of 2019, banking on the following facts: First, in 2019, the company officially collaborated with Horizon, NJ-based UnitedHealthcare and Aetna, placing LabCorp in-network under all major national plans. Ever since, the company has … third quarter. The transaction provides Covance with better global non-clinical research capabilities while sustaining access to bigger research models and services through a multi-year renewable supply agreement. For 2019, on an overall basis …

Fred Hutchinson

Lab Data Coordinator - Fred Hutchinson Cancer Research Center - Seattle, WA | 11/2/2019

Share Description Overview Cures Start Here. At Fred Hutchinson Cancer Research Center, home to three Nobel laureates, interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent, diagnose and treat cancer, HIV … a liaison between the SCHARP lab data management unit and clinical research sites or external labs; and with supervision represent LDM on SCHARP study teams and in internal and external meetings. Help maintain lab, assay …

Post-Doctoral Research Fellow: Affordable methods for genetic editing | Nature | 11/1/2019

Posted about 13 minutes ago Expires on December 31, 2019 Overview Cures Start Here . At Fred Hutchinson Cancer Research Center, home to three Nobel laureates, interdisciplinary teams of world-renowned scientists seek new and innovative … Careers Start Here . Responsibilities The Adair laboratory, housed within the Clinical Research Division, is recruiting a postdoctoral fellow or research associate to study blood cell gene therapy for genetic and infectious diseases and cancer. The …

Mike Nolte

At CNS Summit 2019, Signant Health to Host Spotlight Session Including Speakers from Karuna and Avanir to Discuss the Future of eCOA and Data Analytics to Improve the Patient Experience in Clinical Research | PR Newswire | 10/23/2019

… year, the CNS Summit convenes many of the foremost innovators and thought leaders focused on advancing the patient experience in clinical research through science and technology. Signant Health, formerly CRF Health and Bracket, is proud … idea sharing. The company’s Spotlight Session, led by Signant CEO Mike Nolte , is titled “Putting the Patient First with Predictive Analytics and Smarter eCOA” and takes place on Saturday, November 2 , from 2-3pm EST . Participants …

At CNS Summit 2019, Signant Health to Host Spotlight Session including speakers from Karuna and Avanir to Discuss the Future of eCOA and Data Analytics to Improve the Patient Experience in Clinical Research - PharmaVOICE : PharmaVOICE | 10/23/2019

… year, the CNS Summit convenes many of the foremost innovators and thought leaders focused on advancing the patient experience in clinical research through science and technology. Signant Health, formerly CRF Health and Bracket, is proud … idea sharing. The company’s Spotlight Session, led by Signant CEO Mike Nolte, is titled “Putting the Patient First with Predictive Analytics and Smarter eCOA” and takes place on Saturday, November 2, from 2-3pm EST. Participants …

Blake Schroeder

Medical Marijuana, Inc. Subsidiary Kannaway® Joins U.S. Hemp Roundtable Board of Directors | PR Newswire | 10/22/2019

… Mexico’s Federal Commission for the Protection Against Sanitary Risk (COFEPRIS) and Brazil’s National Sanitary Surveillance Agency (ANVISA),” said Kannaway® CEO Blake Schroeder . “We are honored to have the opportunity to continue these efforts as a … cannabis products derived from industrial hemp; and a cannabinoid-based clinical research and botanical drug development sector led by its internal R&D and scientific team and its pharmaceutical investment companies and partners including AXIM …

Medical Marijuana, Inc. Subsidiary Kannaway® Announces Launch of New Website and Back Office for Japan Division | PR Newswire | 10/10/2019

… look forward to bringing our high-quality cannabidiol (CBD) products to the flourishing Japanese CBD market as well,” Kannaway® CEO Blake Schroeder said. “Kannaway’s new website will allow us to expand access to consumers in … cannabis products derived from industrial hemp; and a cannabinoid-based clinical research and botanical drug development sector led by its internal R&D and scientific team and its pharmaceutical investment companies and partners including AXIM …

Anthony Fauci

Preventive TB Treatment is Safer Postpartum than in Pregnancy in Women with HIV | 10/14/2019

… clinical research, which can lead to an information gap. This can sometimes pose a danger to maternal and infant health, Anthony Fauci, MD, said in a press release . The investigators randomly assigned these women to receive 300 mg isoniazid preventive therapy for 28 weeks, which was initiated either during pregnancy or 12 weeks after delivery. Then, the new mothers and their infants were followed through 48 weeks after delivery. The …

Institute of Human Virology Hosts 21st Annual International Meeting of Top Scientists on Ending the HIV/AIDS Epidemic in America and the Intersection of Opioid Use Disorder | Business Wire | 10/4/2019

… opinions by ADM Brett Giroir, MD , Assistant Secretary for Health at the U.S. Department of Health and Human Services (HHS), Anthony Fauci, MD , Director at the National Institute of Allergy and Infectious Diseases (NIAID) and … The IHV combines the disciplines of basic research, epidemiology and clinical research in a concerted effort to speed the discovery of diagnostics and therapeutics for a wide variety of chronic and deadly viral and immune …

Stuart Titus

Medical Marijuana, Inc. Subsidiary Kannaway® Announces Launch of New Website and Back Office for Japan Division | PR Newswire | 10/10/2019

… excited that Japan is soon to become the next chapter in our Company’s story,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus . “Our Company has remained an industry leader in international expansion into new markets … cannabis products derived from industrial hemp; and a cannabinoid-based clinical research and botanical drug development sector led by its internal R&D and scientific team and its pharmaceutical investment companies and partners including AXIM …

Medical Marijuana, Inc. Subsidiary Kannaway® and Company CEO Honored in 11th Annual Golden Bridge Awards | PR Newswire | 10/8/2019

… 2016 , the Company’s management team has been committed to product innovation and industry advancement,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus . “Blake has been a key player in growing Kannaway and the entire portfolio … cannabis products derived from industrial hemp; and a cannabinoid-based clinical research and botanical drug development sector led by its internal R&D and scientific team and its pharmaceutical investment companies and partners including AXIM …

Travis May

Parexel pens Datavant tech deal for trial workflows | FierceBiotech | 10/10/2019

… Travis May, Co-founder and CEO of Datavant. “After working with Parexel on our initial patient data applications, we’re excited to now expand our strategic partnership to ensure that all data generated through their clinical research process is seamlessly de-identified and made linkable with Datavant technology. “Parexel’s deep clinical expertise positions them well to navigate the planning necessary to include real-world data in the drug development process, and …

Michael J. Fox

Global Composer & Activist Nenad Bach Chairs World Ping Pong Parkinson Championships | PRWeb | 10/10/2019

Clinical Research at the Institute for Neurodegenerative Disorders and Assistant Clinical Professor of Neurology and Psychology at Yale University, who teamed up with the Michael J. Fox Foundation. For those competing in the tournament from around the world, neurological examinations will be given on Friday October 11th and Saturday October 12th. According to the Parkinson’s Foundation, PD affects about 10 million people worldwide, 1 million Americans. About 60,000 new cases …

The Michael J. Fox Foundation Announces $5 Million to Explore Genetics of Parkinson’s Disease in African, East Asian and Indian Populations | 8/27/2019

The Michael J. Fox Foundation Announces $5 Million to Explore Genetics of Parkinson’s Disease in African, East Asian and Indian Populations Published: Aug 27, 2019 Projects aim to genetically test samples from more than 30,000 … of genetic research and commitment to diversity and inclusivity in clinical research participation NEW YORK , Aug. 27, 2019 /PRNewswire/ – The Michael J. Fox Foundation for Parkinson’s Research (MJFF) announces grants totaling nearly $5 million to …

Jackie Drees

Apple’s 5 latest health-related job openings | Becker’s Hospital Review | 10/9/2019

Apple’s 5 latest health-related job openings Jackie Drees - Apple recently posted several job openings related to its health business. Five open positions: 1. Clinical research scientist, health strategic initiatives (hardware): Will oversee design and execution of clinical studies. 2. iOS development manager, health (software and services): Will lead a development team in designing healthcare products. 3. Senior data scientist, health (software and services): Will contribute to the team’s data …

Cerner partners with Duke to launch health network for clinical research | Becker’s Hospital Review | 8/6/2019

Cerner partners with Duke to launch health network for clinical research Jackie Drees - Print Email Cerner is partnering with the Duke Clinical Research Institute to pilot the Cerner Learning Health Network, which aims to automate data collection and expand medical researchers’ access to patient health information. At the Durham, N.C.-based research institute, Duke researchers will use the Cerner Learning Health Network to analyze the use and impact of proven …

David Clair

Bio-Techne To Host Conference Call On October 29, 2019, To Announce First Quarter 2020 Financial Results | PR Newswire | 10/8/2019

… Western blot and multiplexed ELISA workflow. These reagent and protein analysis solutions are sold to biomedical researchers as well as clinical research laboratories and constitute the Protein Sciences Segment. Bio-Techne also develops and manufactures … in fiscal 2019 and has over 2,200 employees worldwide. Contact: David Clair, Senior Director of Investor Relations [email protected] 612-656-4416 SOURCE Bio-Techne Corporation …

Bio-Techne Leverages The RNAscope™ Technology To Advance A Multiomic Approach To Antibody Validation | PR Newswire | 10/7/2019

… NASDAQ: TECH ), a family of brands with a unique and leading portfolio of reagents and instruments for life science and clinical research, has been validating a growing number of immunohistochemistry (IHC) antibodies using the Advanced … visit: www.bio-techne.com . About Bio-Techne Corporation (NASDAQ: TECH ) Contact: David Clair, Senior Director of Investor Relations [email protected] 612-656-4416 SOURCE Bio-Techne Corporation Related Links https://www.bio-techne.com …

Nora Volkow

Institute of Human Virology Hosts 21st Annual International Meeting of Top Scientists on Ending the HIV/AIDS Epidemic in America and the Intersection of Opioid Use Disorder | Business Wire | 10/4/2019

… Health and Human Services (HHS), Anthony Fauci, MD , Director at the National Institute of Allergy and Infectious Diseases (NIAID) and Nora Volkow, MD , Director, National Institute of Drug Abuse (NIDA), among other notable speakers. The … The IHV combines the disciplines of basic research, epidemiology and clinical research in a concerted effort to speed the discovery of diagnostics and therapeutics for a wide variety of chronic and deadly viral and immune …